Research Topics
| Steinar TretliSummaryAffiliation: Cancer Registry of Norway Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based studySteinar Tretli
The Cancer Registry of Norway, Institute of Population Based Cancer Research, Majorstuen, 0304 Oslo, Norway
Cancer Causes Control 23:363-70. 2012..We investigated the association between serum levels of 25-hydroxyvitamin D (25-OHD) and risk of death in Norwegian cancer patients...
Digitoxin medication and cancer; case control and internal dose-response studiesJ Haux
Department of Oncology, University Hospital, N 7006, Trondheim, Norway
BMC Cancer 1:11. 2001..Digitoxin induces apoptosis in different human malignant cell lines in vitro. In this paper we investigated if patients taking digitoxin for cardiac disease have a different cancer incidence compared to the general population...
Birth length and weight as predictors of breast cancer prognosisBjørn O Maehle
Section of Pathology, The Gade Institute, University of Bergen, Bergen, Norway
BMC Cancer 10:115. 2010..Birth size, and particularly birth length, is positively associated with breast cancer risk in adulthood. The objective of this study was to examine whether birth size is associated with survival among breast cancer patients...
Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countriesTom Grotmol
Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway
Cancer Epidemiol Biomarkers Prev 20:1350-7. 2011..The models imply that for a given disease, a minority of individuals are at high risk, compared with the low-risk majority...
Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment useHarald Weedon-Fekjær
Department of Etiological Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, PO Box 5313 Majorstuen, 0304 Oslo, Norway
BMJ 344:e299. 2012..To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008...
Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screeningHarald Weedon-Fekjaer
Kreftregisteret, Institute of Population Based Cancer Research, Montebello, N 0310 Oslo, Norway
J Med Screen 15:83-90. 2008..Using questionnaire data for 336,533 women in the Norwegian Breast Cancer Screening Programme (NBCSP), mean square regression estimates of MST and STS were calculated...
Breast cancer tumor growth estimated through mammography screening dataHarald Weedon-Fekjaer
Department of Etiological Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, Montebello, N 0310 Oslo, Norway
Breast Cancer Res 10:R41. 2008..In the present study based on the Norwegian Breast Cancer Screening Program, tumor growth was estimated from a large population using a new estimating procedure/model...
Cancer risk in Norwegian world class athletesTrude Eid Robsahm
The Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway
Cancer Causes Control 21:1711-9. 2010..As physical activity levels are difficult to measure in the general population, we aimed to investigate how physical activity influences cancer risk using a cohort of Norwegian world class athletes...
Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implicationsFreddie Bray
The Cancer Registry of Norway, Institute of Population Based Cancer Research, Montebello, N 0310 Oslo, Norway
Cancer Epidemiol Biomarkers Prev 17:2356-65. 2008..A modified model for NPC tumor development is proposed on the basis of these observations...
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countriesRune Kvåle
The Cancer Registry of Norway, 0310 Oslo, Norway
J Natl Cancer Inst 99:1881-7. 2007..Although other explanatory factors may be in operation, these trends are consistent with a moderate effect of increased curative treatment of early diagnosed prostate cancer and improved treatment of more advanced disease...
Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new resultsHarald Weedon-Fekjaer
Kreftregisteret, Institute of Population Based Cancer Research, Montebello, N 0310, Oslo, Norway
J Med Screen 12:172-8. 2005....
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)Trude Eid Robsahm
The Cancer Registry of Norway, Institute of Population Based Cancer Research, Montebello, 0310 Oslo, Norway
Cancer Causes Control 15:149-58. 2004..To investigate whether prognosis of breast-, colon- and prostate cancer may be related to vitamin D(3), induced from solar ultra-violet (UV) radiation, through studies on geographical and seasonal variations in UV radiation...
